FDA Inspection 1076860 — LifeServe Blood Center
The FDA completed an inspection of LifeServe Blood Center on December 18, 2018 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 18, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Omaha, NE (United States)